The CEO Of This Innovative BioPharma Is Bringing Light To Cancer Research from se 100 tak ka ginti hindi me Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 15:1 👁 View: 55K times ✓ Published: 27-Mar-2024
Description: Paul Peter Tak, MD, PhD, FMedSci, President & CEO of Candel Therapeutics, was recently a guest on Benzinga's All-Acess.<br/><br/>Candel is a clinical-stage biopharmaceutical company focused on developing immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The company has two main platforms that are currently undergoing clinical trials. <br/><br/>Candel also has its enLIGHTEN™ program, a systematic, iterative discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors.
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)